HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS

LATEST UPDATES » Vol 22, No 09, September 2018 – Doctor Robot - The digital healthcare revolution       » Gene helps rice adapt to colder climates       » 'Longevity protein' found effective in primates       » Korean beef inhibits proliferation of colorectal cancer cells       » First 3D printed human corneas       » Zombie gene protects against cancer in elephants      
EDITOR'S LETTER
We all know human beings breathe to stay alive. However, how often are we consciously mindful of how important a pair of healthy lungs are? What would happen if our lungs malfunction because of growing cancer cells?

In this APBN January 2017 issue, we will explore several treatment options for lung diseases and lung cancer:

At the IASLC 17th World Conference on Lung Cancer (WCLC), researchers presented their clinical trials that showed the promising progress of immunotherapy in lung cancer treatment. For instance, data from the KEYNOTE-024 trial showed that patients who received immunotherapy, pembrolizumab, are having a better quality of life than those that received chemotherapy.

Chronic Obstructive Pulmonary Disease (COPD) typically affects patients above the age of 50 and its main cause is smoking. APBN interviewed Professor Norbert Berend, an expert in respiratory research, who talked about Salford Lung Study (SLS). Sponsored by GSK, SLS was conducted to explore the effectiveness and safety of Relvar®Ellipta® in COPD patients in a real-life setting. You can check out this article in the Features section, as well as find out more about COPD, its difference from asthma, and available treatments.

In Singapore, a systematic molecular profiling of lung cancers will be conducted by researchers to understand the disease in more depth, and in turn explore novel treatment options in order to better tailor to the needs of different lung cancer patients (Refer to "Lung Cancer Treatment" in Features).

Jumping into the Spotlights section, new data from the PLANET study showed Aflibercept as an effective monotherapy for patients with PCV, an age-related eye disease.

Dr. Anita Damodaran, a scientist from The Pond's Institute, shared a breakthrough finding from their research on the role that inflammation plays in acne pathogenesis, and discovered a new approach to tackle inflammation and reduce acne lesions. She suggested that acne is best treated by taking a holistic approach which includes both dietary/nutrition and topical interventions. If you are seeking career opportunities in the healthcare industry, an interview article with Ms Goh from Roche Diagnostics would be insightful as she shares tips of the trade.

As always, you can access APBN's latest issue online on www.asiabiotech.com. You can also check out our Facebook page @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

May APBN be a great companion for you in your free time. Happy New Year.

Thank you.


Carmen, Jia Wen Loh
APBN Editor
You can reach me at jwloh@wspc.com

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy